Northwire Canada EditionWednesday, July 15, 2026
Northwire
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Financings

Comprehensive Healthcare closes $3.5M first tranche

CHS · Price

Executive Summary

  • Comprehensive Healthcare Systems Inc. has closed the first tranche of its non-brokered private placement, raising $3.5 million in gross proceeds.
  • The company issued 7 million units at $0.50 per unit, with each unit consisting of one common share and one-half of a warrant.
  • Insider participation accounted for 13.5% of the tranche, triggering specific regulatory exemptions under MI 61-101 regarding related party transactions.

Key Details

  • Transaction Structure: Non-brokered private placement, first tranche closed.
  • Units Issued: 7,000,000 units.
  • Price Per Unit: $0.50 CAD.
  • Gross Proceeds: $3,500,000 CAD.
  • Warrant Terms (Investors): Each unit includes one-half of a warrant. A whole warrant is exercisable to purchase one common share at an exercise price of $1.00. The warrants are exercisable for a period of three years after closing.
  • Finder Fees: PowerOne Capital Markets Ltd. acted as finder. The company paid $214,200 in cash finder fees.
  • Finder Warrants: The company issued 428,400 finder warrants, exercisable to purchase one common share at an exercise price of $0.50 for a period of three years after closing.
  • Hold Period: All securities issued are subject to a hold period until June 11, 2026.
  • Insider Participation: An insider purchased 945,000 units, representing 13.5% of the units issued in the first tranche.
  • Insider Ownership Impact: The associated common shares represent approximately 3.8% of the issued and outstanding shares upon closing. Assuming the deemed exercise of the associated warrants, this would represent approximately 5.6% of the then issued and outstanding shares.
  • Regulatory Exemptions: The transaction is classified as a related party transaction under TSX-V and Multilateral Instrument 61-101. The company relied on exemptions from formal valuation and minority shareholder approval requirements (sections 5.5(a) and (b), and 5.7(1)(a) of MI 61-101) because the fair market value of the consideration involving related parties did not exceed 25% of the issuer's market capitalization.
Read the original news release →

More from Comprehensive Healthcare Systems Inc